MedPath

Feasibility study of S-1 for adjuvant chemotherapy in Biliary-Pancreatic cancer

Not Applicable
Recruiting
Conditions
Biliary-Pancreatic cancer
Registration Number
JPRN-UMIN000004922
Lead Sponsor
Osaka City University Graduate School of Medicine,Department of Hepato-Biliary-Pancreatic Surgery
Brief Summary

discontinuance

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1
Inclusion Criteria

Not provided

Exclusion Criteria

1)previous treatment of S-1 2)recurrent case 3)fibroid lung or interstitial lung disease 4)active infectiou disease (excluding viral hepatitis) 5)sever complication 6)moderate ascites or pleural effusion 7)double cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath